Mary K. O’Reilly

685 total citations
10 papers, 546 citations indexed

About

Mary K. O’Reilly is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mary K. O’Reilly has authored 10 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mary K. O’Reilly's work include Glycosylation and Glycoproteins Research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Mary K. O’Reilly is often cited by papers focused on Glycosylation and Glycoproteins Research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Mary K. O’Reilly collaborates with scholars based in United States, Germany and Ireland. Mary K. O’Reilly's co-authors include James C. Paulson, Hua Tian, Barbara Imperiali, Liang Liao, Guofeng Zhang, Shoufa Han, Lei Zhao, Jean Chmielewski, Michael D. Shultz and M. G. Finn and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Immunology and Biochemistry.

In The Last Decade

Mary K. O’Reilly

10 papers receiving 540 citations

Peers

Mary K. O’Reilly
Kévin Canis United Kingdom
Oyindasola Oyelaran United States
Baptiste Aussedat United States
Lohitha Basa United States
J D Fontenot United States
A. Roche France
Maria Duk Poland
Kévin Canis United Kingdom
Mary K. O’Reilly
Citations per year, relative to Mary K. O’Reilly Mary K. O’Reilly (= 1×) peers Kévin Canis

Countries citing papers authored by Mary K. O’Reilly

Since Specialization
Citations

This map shows the geographic impact of Mary K. O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary K. O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary K. O’Reilly more than expected).

Fields of papers citing papers by Mary K. O’Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary K. O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary K. O’Reilly. The network helps show where Mary K. O’Reilly may publish in the future.

Co-authorship network of co-authors of Mary K. O’Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Mary K. O’Reilly. A scholar is included among the top collaborators of Mary K. O’Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary K. O’Reilly. Mary K. O’Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kędziora, Kinga, Mary K. O’Reilly, Brian Keogh, et al.. (2012). Azo-reductase activated budesodine prodrugs for colon targeting. Bioorganic & Medicinal Chemistry Letters. 22(24). 7573–7577. 16 indexed citations
2.
Udit, Andrew K., Christian P. R. Hackenberger, & Mary K. O’Reilly. (2010). Chemically Tailored Multivalent Virus Platforms: From Drug Delivery to Catalysis. ChemBioChem. 11(4). 481–484. 6 indexed citations
3.
O’Reilly, Mary K. & James C. Paulson. (2010). Multivalent Ligands for Siglecs. Methods in enzymology on CD-ROM/Methods in enzymology. 478. 343–363. 31 indexed citations
4.
O’Reilly, Mary K., Hua Tian, & James C. Paulson. (2010). CD22 Is a Recycling Receptor That Can Shuttle Cargo between the Cell Surface and Endosomal Compartments of B Cells. The Journal of Immunology. 186(3). 1554–1563. 91 indexed citations
5.
O’Reilly, Mary K. & James C. Paulson. (2009). Siglecs as targets for therapy in immune-cell-mediated disease. Trends in Pharmacological Sciences. 30(5). 240–248. 149 indexed citations
6.
O’Reilly, Mary K., Brian E. Collins, Shoufa Han, et al.. (2008). Bifunctional CD22 Ligands Use Multimeric Immunoglobulins as Protein Scaffolds in Assembly of Immune Complexes on B Cells. Journal of the American Chemical Society. 130(24). 7736–7745. 62 indexed citations
7.
Kaltgrad, Eiton, Mary K. O’Reilly, Liang Liao, et al.. (2008). On-Virus Construction of Polyvalent Glycan Ligands for Cell-Surface Receptors. Journal of the American Chemical Society. 130(14). 4578–4579. 65 indexed citations
8.
O’Reilly, Mary K., Guofeng Zhang, & Barbara Imperiali. (2006). In Vitro Evidence for the Dual Function of Alg2 and Alg11:  Essential Mannosyltransferases in N-Linked Glycoprotein Biosynthesis. Biochemistry. 45(31). 9593–9603. 57 indexed citations
9.
Zhao, Lei, Mary K. O’Reilly, Michael D. Shultz, & Jean Chmielewski. (2003). Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization. Bioorganic & Medicinal Chemistry Letters. 13(6). 1175–1177. 50 indexed citations
10.
Peluso, Stéphane, et al.. (2002). Neoglycopeptides as Inhibitors of Oligosaccharyl Transferase. Chemistry & Biology. 9(12). 1323–1328. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026